Golden State Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$691K Buy
2,747
+37
+1% +$7.96K 0.06% 239
2026
Q1
$590K Buy
2,710
+225
+9% +$49.9K 0.06% 223
2025
Q4
$568K Sell
2,485
-150
-6% -$34.2K 0.06% 228
2025
Q3
$610K Buy
2,635
+8
+0.3% +$1.63K 0.07% 216
2025
Q2
$488K Buy
2,627
+503
+24% +$93.5K 0.06% 243
2025
Q1
$445K Buy
2,124
+93
+5% +$18.1K 0.07% 221
2024
Q4
$361K Buy
+2,031
New +$373K 0.05% 247
2022
Q1
$568K Sell
3,504
-6,789
-66% -$986K 0.11% 163
2021
Q4
$1.39M Buy
10,293
+5,545
+117% +$655K 0.24% 84
2021
Q3
$512K Sell
4,748
-106
-2% -$12.1K 0.11% 156
2021
Q2
$547K Sell
4,854
-271
-5% -$30.5K 0.12% 153
2021
Q1
$554K Sell
5,125
-6,472
-56% -$692K 0.18% 95
2020
Q4
$1.24M Sell
11,597
-687
-6% -$66K 0.36% 54
2020
Q3
$1.07M Sell
12,284
-1,629
-12% -$153K 0.36% 44
2020
Q2
$1.36M Buy
13,913
+3,917
+39% +$345K 0.44% 37
2020
Q1
$762K Buy
+9,996
New +$851K 0.34% 51
2019
Q4
Sell
-10,244
Closed -$776K 60
2019
Q3
$776K Buy
10,244
+6,411
+167% +$440K 0.26% 74
2019
Q2
$278K Buy
3,833
+153
+4% +$12K 0.09% 179
2019
Q1
$297K Buy
+3,680
New +$301K 0.1% 168

Other funds holding ABBV

Golden State Wealth Management's ABBV Position: Q2 2026 in Review

Golden State Wealth Management increased its AbbVie (ABBV) stake by 1.4% in Q2 2026, buying an estimated $7.96K and bringing the position to 2,747 shares worth $691K. The position accounts for 0.06% of the portfolio, ranked #239.

Golden State Wealth Management first reported a position in ABBV in Q1 2019 and has held it in 19 quarters since. The position peaked at $1.39M in Q4 2021. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Golden State Wealth Management held 2,747 shares of AbbVie worth $691K as of Q2 2026.
  • Golden State Wealth Management bought 37 AbbVie shares in Q2 2026, an estimated $7.96K.
  • AbbVie made up 0.06% of Golden State Wealth Management's portfolio in Q2 2026, its #239 holding.
  • Golden State Wealth Management first reported a position in AbbVie in Q1 2019 and has held it in 19 quarters since.
  • Golden State Wealth Management's AbbVie position peaked at $1.39M in Q4 2021.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.